Rafferty Asset Management
IMGN

Rafferty Asset Management’s Immunogen Inc IMGN Stock Holding History

Rafferty Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-307,369
Closed -$9.11M – 1104
2023
Q4 		$9.11M Sell
307,369
-259,616
-46% -$5.17M 0.04% 305
2023
Q3 		$9M Buy
566,985
+229,699
+68% +$3.82M 0.05% 249
2023
Q2 		$6.36M Sell
337,286
-1,030,684
-75% -$12.2M 0.04% 358
2023
Q1 		$5.25M Sell
1,367,970
-243
-0% -$1.04K 0.04% 373
2022
Q4 		$6.79M Buy
1,368,213
+420,762
+44% +$2.28M 0.06% 308
2022
Q3 		$4.53M Buy
947,451
+199,435
+27% +$1.05M 0.05% 352
2022
Q2 		$3.37M Sell
748,016
-104,868
-12% -$456K 0.03% 367
2022
Q1 		$4.06M Buy
852,884
+439,850
+106% +$2.44M 0.02% 427
2021
Q4 		$3.06M Buy
413,034
+109,741
+36% +$682K 0.02% 533
2021
Q3 		$1.72M Sell
303,293
-99,253
-25% -$574K 0.01% 678
2021
Q2 		$2.65M Buy
402,546
+24,784
+7% +$173K 0.02% 555
2021
Q1 		$3.06M Buy
377,762
+298,247
+375% +$2.44M 0.02% 481
2020
Q4 		$513K Sell
79,515
-149,605
-65% -$873K 0.01% 682
2020
Q3 		$825K Buy
229,120
+127,933
+126% +$517K 0.01% 605
2020
Q2 		$465K Buy
101,187
+86,546
+591% +$368K 0.01% 732
2020
Q1 		$50K Sell
14,641
-109,672
-88% -$479K ﹤0.01% 574
2019
Q4 		$635K Sell
124,313
-195,676
-61% -$664K 0.01% 651
2019
Q3 		$774K Buy
+319,989
New +$850K 0.01% 593
2019
Q2 		– Sell
-722,765
Closed -$1.96M – 863
2019
Q1 		$1.96M Buy
+722,765
New +$3.13M 0.03% 403

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rafferty Asset Management's IMGN Position: Q1 2024 in Review

Rafferty Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 307,369 shares — an estimated $9.11M sold.

Rafferty Asset Management first reported a position in IMGN in Q1 2019 and held it in 19 quarters. The position peaked at $9.11M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Rafferty Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 307,369 Immunogen Inc shares in Q1 2024, an estimated $9.11M.
  • Rafferty Asset Management first reported a position in Immunogen Inc in Q1 2019 and held it in 19 quarters.
  • Rafferty Asset Management's Immunogen Inc position peaked at $9.11M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Rafferty Asset Management's 13F filing for Q1 2024, filed 13 May 2024.